Literature DB >> 12436112

The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion.

Alexandra Flemming1, Tilman Brummer, Michael Reth, Hassan Jumaa.   

Abstract

Mice deficient in the adaptor protein SLP-65 (also known as BLNK) have reduced numbers of mature B cells, but an increased pre-B cell compartment. We show here that compared to wild-type cells, SLP-65(-/-) pre-B cells show an enhanced ex vivo proliferative capacity. This proliferation requires interleukin 7 and expression of the pre-B cell receptor (pre-BCR). In addition, SLP-65(-/-) mice have a high incidence of pre-B cell lymphoma. Reintroduction of SLP-65 into SLP-65(-/-) pre-B cells led to pre-BCR down-regulation and enhanced differentiation. Our results indicate that SLP-65 regulates a developmental program that promotes differentiation and limits pre-B cell expansion, thereby acting as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436112     DOI: 10.1038/ni862

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  62 in total

1.  Testing gene function early in the B cell lineage in mb1-cre mice.

Authors:  E Hobeika; S Thiemann; B Storch; H Jumaa; P J Nielsen; R Pelanda; M Reth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-29       Impact factor: 11.205

Review 2.  Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.

Authors:  Sebastian Herzog; Bettina Storch; Hassan Jumaa
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

4.  Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.

Authors:  Rahul Nahar; Parham Ramezani-Rad; Maximilian Mossner; Cihangir Duy; Leandro Cerchietti; Huimin Geng; Sinisa Dovat; Hassan Jumaa; B Hilda Ye; Ari Melnick; Markus Müschen
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

5.  Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity.

Authors:  Adam S Potter; Angelo J Casa; Adrian V Lee
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

Review 6.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

7.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

8.  Pre-B cell receptor signaling in acute lymphoblastic leukemia.

Authors:  Rahul Nahar; Markus Müschen
Journal:  Cell Cycle       Date:  2009-12-09       Impact factor: 4.534

9.  The Sel1L-Hrd1 Endoplasmic Reticulum-Associated Degradation Complex Manages a Key Checkpoint in B Cell Development.

Authors:  Yewei Ji; Hana Kim; Liu Yang; Haibo Sha; Christopher A Roman; Qiaoming Long; Ling Qi
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

Review 10.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.